IGMS
IGM Biosciences
IGMS
IGMS
Delisted
IGMS was delisted on the 13th of August, 2025.
72 hedge funds and large institutions have $357M invested in IGM Biosciences in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 24 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
12% less funds holding
Funds holding: 82 → 72 (-10)
47% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 19
Holders
72
Holding in Top 10
2
Calls
$1.2M
Puts
$863K
Top Buyers
| 1 | +$3.69M | |
| 2 | +$942K | |
| 3 | +$486K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$465K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$326K |
Top Sellers
| 1 | -$22.9M | |
| 2 | -$4.28M | |
| 3 | -$1.24M | |
| 4 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$1.06M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.01M |